Portfolio (Quarterly)
Guide ↗
Ally Bridge Group (NY) LLC
· CIK 0001822947| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MAZE CALL | MAZE THERAPEUTICS INC | Healthcare | 100,000.0 | $3.0M | 2.41% | NEW | — | $29.85 | -17.9% |
| 22 | WHWK | WHITEHAWK THERAPEUTICS INC | Healthcare | 817,939.0 | $2.8M | 2.28% | NEW | — | $3.45 | +23.2% |
| 23 | — | INHIBIKASE THERAPEUTICS INC | — | 1,325,000.0 | $2.2M | 1.80% | NEW | — | $1.68 | — |
| 24 | REPL CALL | REPLIMUNE GROUP INC | Healthcare | 246,900.0 | $1.9M | 1.52% | NEW | — | $7.65 | -34.5% |
| 25 | ANTX | AN2 THERAPEUTICS INC | Healthcare | 526,315.0 | $1.8M | 1.45% | NEW | — | $3.42 | +33.0% |
| 26 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 210,525.0 | $1.5M | 1.18% | NEW | — | $6.96 | -8.9% |
| 27 | KPTI CALL | KARYOPHARM THERAPEUTICS INC | Healthcare | 250,000.0 | $1.4M | 1.12% | NEW | — | $5.57 | +34.1% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%